NCT06047951

Brief Summary

The goal of this clinical trial is to confirm the feasibility and safety of performing radiosurgery on unruptured, low-risk aneurysms in humans. Participants will choose if they want to undergo radiosurgery or not. Participants who choose not to have radiosurgery will be assigned to the observational group. Participants who choose to have radiosurgery performed will be assigned to the radiosurgery group. Participants in both groups will attend an initial exam session as well as four follow-up sessions: Day 0

  • Initial questionnaire
  • CTA scan
  • MRI
  • Radiosurgery performed on patients in the radiosurgery group 6 months
  • CTA scan
  • Follow-up questionnaire 12 months
  • CTA scan
  • MRI
  • Follow-up questionnaire 24 months
  • CTA scan
  • Follow-up questionnaire 36 months
  • CTA scan
  • MRI
  • Follow-up questionnaire Researchers will compare the observational group and the radiosurgery group to see if there is a difference in the incidence of aneurysm rupture during the study period (3 years). The hypothesis is that radiosurgery should not increase the risk of aneurysm rupture.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
48mo left

Started Jun 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Jun 2025Jun 2030

First Submitted

Initial submission to the registry

September 15, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
1.7 years until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2030

Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

5 years

First QC Date

September 15, 2023

Last Update Submit

February 12, 2025

Conditions

Keywords

brain aneurysm, radiosurgery, intracranial aneurysm

Outcome Measures

Primary Outcomes (1)

  • Between group difference in the incidence of aneurysm rupture during the study period

    The hypothesis is that SRS should not increase this risk.

    3 years from SRS

Secondary Outcomes (5)

  • Incidence of any radiation-induced complications

    3 years

  • Incidence of endovascular or surgical aneurysm treatment during the latency period

    3 years

  • Change in aneurysm volume relative to baseline

    3 years

  • Change in aneurysm shape indices relative to baseline

    3 years

  • Aneurysm occlusion confirmed by CT-angiography (CTA)

    at 3 years from SRS

Study Arms (2)

SRS group

EXPERIMENTAL

Participants in the SRS group will receive the intervention described earlier, consisting of a Gamma Knife radiosurgery, and undergo the same follow-up exams (radiological and clinical) as participants of the control group.

Procedure: Stereotactic RadioSurgery (SRS)

Control group

NO INTERVENTION

The medical care will consist of observation for any element that may indicate an increased risk of rupture, like aneurysm growth or instability in shape.

Interventions

All treatments will be performed using the Gamma Knife Perfexion or Icon system (Elekta). The following treatment parameters will be used: * The head will be immobilized using a stereotactic Leksell Model G frame, installed using local protocols * Targeting will be performed by using a stereotactic CTA. No MRI will be performed. * Only one aneurysm will be treated per patient * The aneurysm, including its neck, will be contoured and targeted using a combination of 4mm isocenters as deemed appropriate by the treating team * A prescription dose of 25 Gy at the margin of the target will be used * The maximal dose on optic pathways will be kept below 10 Gy * The brainstem 12-Gy volume will be kept below 1cc

Also known as: Gamma Knife SRS
SRS group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Medical imaging (CTA, MRA or digital substraction angiography) reveals the existence of an asymptomatic unruptured saccular anterior circulation intracranial aneurysm under 7 mm
  • Advised by a vascular neurosurgeon to observe rather than undergo endovascular or microsurgical management

You may not qualify if:

  • Prior history of aneurysmal rupture
  • Presence of symptoms that could be attributed to the aneurysm (severe headache, third cranial nerve deficits, or others)
  • Imaging features deemed to increase rupture risk as evaluated by the treating physician
  • Posterior circulation aneurysm
  • Fusiform aneurysm
  • Dissecting aneurysm
  • Mycotic aneurysm
  • Direct contact between the aneurysm and the optic pathways on medical imaging
  • Prior coils or clips in the targeted aneurysm or any other aneurysm
  • Patient unable to consent
  • Patient unable or unlikely to comply with the follow-up schedule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, Quebec, J1H 5N4, Canada

Location

Related Publications (25)

  • Kleinloog R, de Mul N, Verweij BH, Post JA, Rinkel GJE, Ruigrok YM. Risk Factors for Intracranial Aneurysm Rupture: A Systematic Review. Neurosurgery. 2018 Apr 1;82(4):431-440. doi: 10.1093/neuros/nyx238.

    PMID: 28498930BACKGROUND
  • Bonneville F, Sourour N, Biondi A. Intracranial aneurysms: an overview. Neuroimaging Clin N Am. 2006 Aug;16(3):371-82, vii. doi: 10.1016/j.nic.2006.05.001.

    PMID: 16935705BACKGROUND
  • Meadowcroft MD, Cooper TK, Rupprecht S, Wright TC, Neely EE, Ferenci M, Kang W, Yang QX, Harbaugh RE, Connor JR, McInerney J. Gamma Knife radiosurgery of saccular aneurysms in a rabbit model. J Neurosurg. 2018 Dec 1;129(6):1530-1540. doi: 10.3171/2017.6.JNS17722. Epub 2018 Jan 12.

    PMID: 29328001BACKGROUND
  • Erratum: Management of unruptured intracranial aneurysms. Neurol Clin Pract. 2014 Apr;4(2):98. doi: 10.1212/CPJ.0000000000000019.

    PMID: 29443238BACKGROUND
  • Flemming KD, Lanzino G. Management of Unruptured Intracranial Aneurysms and Cerebrovascular Malformations. Continuum (Minneap Minn). 2017 Feb;23(1, Cerebrovascular Disease):181-210. doi: 10.1212/CON.0000000000000418.

    PMID: 28157750BACKGROUND
  • Schievink WI. Intracranial aneurysms. N Engl J Med. 1997 Jan 2;336(1):28-40. doi: 10.1056/NEJM199701023360106. No abstract available.

    PMID: 8970938BACKGROUND
  • Fusco MR, Ogilvy CS. Surgical and endovascular management of cerebral aneurysms. Int Anesthesiol Clin. 2015 Winter;53(1):146-65. doi: 10.1097/AIA.0000000000000038. No abstract available.

    PMID: 25551747BACKGROUND
  • Brown RD Jr, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol. 2014 Apr;13(4):393-404. doi: 10.1016/S1474-4422(14)70015-8.

    PMID: 24646873BACKGROUND
  • Burns JD, Brown RD Jr. Treatment of unruptured intracranial aneurysms: surgery, coiling, or nothing? Curr Neurol Neurosci Rep. 2009 Jan;9(1):6-12. doi: 10.1007/s11910-009-0002-0.

    PMID: 19080747BACKGROUND
  • Truelsen T, Bonita R, Duncan J, Anderson NE, Mee E. Changes in subarachnoid hemorrhage mortality, incidence, and case fatality in New Zealand between 1981-1983 and 1991-1993. Stroke. 1998 Nov;29(11):2298-303. doi: 10.1161/01.str.29.11.2298.

    PMID: 9804637BACKGROUND
  • Qureshi AI, Suri MF, Nasar A, Kirmani JF, Divani AA, He W, Hopkins LN. Trends in hospitalization and mortality for subarachnoid hemorrhage and unruptured aneurysms in the United States. Neurosurgery. 2005 Jul;57(1):1-8; discussion 1-8. doi: 10.1227/01.neu.0000163081.55025.cd.

    PMID: 15987534BACKGROUND
  • Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006 Aug 31;355(9):928-39. doi: 10.1056/NEJMra052760. No abstract available.

    PMID: 16943405BACKGROUND
  • Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005 Sep 3-9;366(9488):809-17. doi: 10.1016/S0140-6736(05)67214-5.

    PMID: 16139655BACKGROUND
  • Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003 Jul 12;362(9378):103-10. doi: 10.1016/s0140-6736(03)13860-3.

    PMID: 12867109BACKGROUND
  • Froelich JJ, Neilson S, Peters-Wilke J, Dubey A, Thani N, Erasmus A, Carr MW, Hunn AW. Size and Location of Ruptured Intracranial Aneurysms: A 5-Year Clinical Survey. World Neurosurg. 2016 Jul;91:260-5. doi: 10.1016/j.wneu.2016.04.044. Epub 2016 Apr 20.

    PMID: 27108026BACKGROUND
  • Starke RM, Kano H, Ding D, Lee JY, Mathieu D, Whitesell J, Pierce JT, Huang PP, Kondziolka D, Yen CP, Feliciano C, Rodgriguez-Mercado R, Almodovar L, Pieper DR, Grills IS, Silva D, Abbassy M, Missios S, Barnett GH, Lunsford LD, Sheehan JP. Stereotactic radiosurgery for cerebral arteriovenous malformations: evaluation of long-term outcomes in a multicenter cohort. J Neurosurg. 2017 Jan;126(1):36-44. doi: 10.3171/2015.9.JNS151311. Epub 2016 Mar 4.

    PMID: 26943847BACKGROUND
  • Kim BS, Kim KH, Lee MH, Lee JI. Stereotactic Radiosurgery for Brainstem Cavernous Malformations: An Updated Systematic Review and Meta-Analysis. World Neurosurg. 2019 Oct;130:e648-e659. doi: 10.1016/j.wneu.2019.06.183. Epub 2019 Jul 2.

    PMID: 31276856BACKGROUND
  • Grady C, Gesteira Benjamin C, Kondziolka D. Radiosurgery for dural arteriovenous malformations. Handb Clin Neurol. 2017;143:125-131. doi: 10.1016/B978-0-444-63640-9.00012-6.

    PMID: 28552134BACKGROUND
  • Schneider BF, Eberhard DA, Steiner LE. Histopathology of arteriovenous malformations after gamma knife radiosurgery. J Neurosurg. 1997 Sep;87(3):352-7. doi: 10.3171/jns.1997.87.3.0352.

    PMID: 9285598BACKGROUND
  • Lan Z, Li J, You C, Chen J. Successful use of Gamma Knife surgery in a distal lenticulostriate artery aneurysm intervention. Br J Neurosurg. 2012 Feb;26(1):89-90. doi: 10.3109/02688697.2011.591949. Epub 2011 Jul 18.

    PMID: 21767129BACKGROUND
  • Liscak R, Vymazal J, Chytka T. Gamma Knife Radiosurgery of Distal Aneurysm: A Case Series. Stereotact Funct Neurosurg. 2021;99(5):381-386. doi: 10.1159/000513956. Epub 2021 Mar 17.

    PMID: 33730736BACKGROUND
  • Raghavan ML, Ma B, Harbaugh RE. Quantified aneurysm shape and rupture risk. J Neurosurg. 2005 Feb;102(2):355-62. doi: 10.3171/jns.2005.102.2.0355.

    PMID: 15739566BACKGROUND
  • Ding D, Xu Z, Starke RM, Yen CP, Shih HH, Buell TJ, Sheehan JP. Radiosurgery for Cerebral Arteriovenous Malformations with Associated Arterial Aneurysms. World Neurosurg. 2016 Mar;87:77-90. doi: 10.1016/j.wneu.2015.11.080. Epub 2015 Dec 28.

    PMID: 26732956BACKGROUND
  • Kim M, Pyo S, Jeong Y, Lee S, Jung Y, Jeong H. Gamma Knife surgery for intracranial aneurysms associated with arteriovenous malformations. J Neurosurg. 2006 Dec;105 Suppl:229-34. doi: 10.3171/sup.2006.105.7.229.

    PMID: 18503361BACKGROUND
  • Vymazal J, Liscak R, Novotny J Jr, Janouskova L, Vladyka V. The role of Gamma Knife radiosurgery in arteriovenous malformation with aneurysms. Stereotact Funct Neurosurg. 1999;72 Suppl 1:175-84. doi: 10.1159/000056454.

    PMID: 10681706BACKGROUND

MeSH Terms

Conditions

Intracranial Aneurysm

Interventions

Radiosurgery

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

RadiotherapyTherapeuticsStereotaxic TechniquesNeurosurgical ProceduresSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • David Mathieu, MD FRCS(C)

    Service de neurochirurgie, Département de chirurgie, Centre hospitalier universitaire de Sherbrooke

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Mathieu, M.D. FRCS(C)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study population will consist of adult men and women with a CTA-proven UIA under 7 mm who were advised to not undergo treatment because of its low rupture risk. The sample will consist of consecutively enrolled patients seen for a vascular neurosurgical consult or follow-up in the outpatient clinic of participating centers. All eligible patients will be offered to participate in the study at the next follow-up. Enrolled patients will then decide if they want to undergo SRS or if they prefer to continue being managed expectantly. Patients who decide to undergo SRS will be treated with radiosurgery according to the study protocol, while patients who decline SRS will be enrolled in a control, prospective, observational cohort with the same follow-up protocol as the SRS cohort. Furthermore, patients harbouring multiple UIAs will only be treated for one lesion. There will be no randomization or blinding.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of the Division of Neurosurgery

Study Record Dates

First Submitted

September 15, 2023

First Posted

September 21, 2023

Study Start

June 1, 2025

Primary Completion (Estimated)

June 1, 2030

Study Completion (Estimated)

June 1, 2030

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

No individual participant data will be made available to other researchers.

Locations